PTEN and cancer: Notably, activating mutations in the catalytic domain of PI3K, i.e., PIK3CA, and loss-of-function mutations in PTEN are among the most common genetic alterations found in human cancer, demonstrating the central role of this phosphoinositide in cancer biology (Engelman, 2009).